Topotecan Completed Phase 1 Trials for Primary Peritoneal Cavity Cancer / Cancer of the Ovary Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00002734Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer
NCT00005026Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
NCT00250094Clinical Benefit of Topoisomerase Downregulation